In cancers, the upregulation of HER4, a member of the epidermal growth factor receptor (EGFR) family, increases metabolic processes associated with tumor promotion, including glycolysis, OXPHOS, and glutaminolysis [10]. Here, EGFR is linked to neoplasm.